Advisory: (OFFICIAL)-Alerts on Petros Pharma deal withdrawn as company clarifies
28/07/2022 15:55
July 28 (Reuters) - The alerts on Petros Pharmaceuticals
PTPI.O being taken private by Henry Crown and Company for
$3.25 per share have been withdrawn after the company clarified
its statement on the deal was "fraudulent and not issued by the
Company". FWN2Z97IG
The company is not a party to any such acquisition and has
reported the fraudulent activity to the Nasdaq, Petros
Pharmaceuticals said in a statement.
STORY_NUMBER: FWN2Z95WV
STORY_DATE: 28/07/2022
STORY_TIME: 01:25:12
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions